Clinical Trials Browser

Terminated × NIH × becatecarin × Clear all

NCT00084487 2014-05-23

Rebeccamycin Analog as Second-Line Therapy in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer That Relapsed After Previous First-Line Chemotherapy

Phase 2 Terminated

21 enrolled 12 charts

Small Cell Lung Carcinoma

NCT00086983 2013-01-10

Rebeccamycin Analog and Oxaliplatin in Treating Patients With Refractory Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific